Self-Amplifying RNA: Advantages and Challenges of a Versatile Platform for Vaccine Development
Self-amplifying RNA is synthetic nucleic acid engineered to replicate within cells without generating viral particles. Derived from alphavirus genomes, saRNA retains the non-structural elements essential for replication while replacing the structural elements with an antigen of interest. By enabling...
Saved in:
| Main Authors: | Thomas Vallet, Marco Vignuzzi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/17/4/566 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Co‐expression of HSV‐1 ICP34.5 enhances the expression of gene delivered by self‐amplifying RNA and mitigates its immunogenicity
by: Xuemin Lu, et al.
Published: (2025-07-01) -
Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza
by: Ziqi Cheng, et al.
Published: (2024-12-01) -
Development of mRNA rabies vaccines
by: Zixin Fang, et al.
Published: (2024-12-01) -
Laminar fluid ejection device enables high yield and preservation of mRNA and SaRNA LNP formulations
by: Chia Hao Ho, et al.
Published: (2025-05-01) -
Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals
by: Jonathan Kitonsa, et al.
Published: (2025-05-01)